Navigation Links
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
Date:1/31/2013

THURSDAY, Jan. 31 (HealthDay News) -- Each injection drug user with hepatitis C is likely to infect about 20 other people, and half of those transmissions occur in the first two years after the initial infection, new research shows.

The findings indicate that early diagnosis and treatment of hepatitis C in injection drug users -- called "super-spreaders" -- could prevent many cases of hepatitis C, the researchers said.

The hepatitis C virus is spread through contact with infected blood, having sex with an infected person and from mother to baby during childbirth. Hepatitis C can lead to scarring of the liver or liver cancer. Some patients require a liver transplant. There is no vaccine for the disease.

The researchers combined epidemiological and molecular data to determine how hepatitis C spreads in a population.

"For the first time we show that super-spreading in hepatitis C is led by intravenous drug users early in their infection," study author Gkikas Magiorkinis, of the zoology department at the University of Oxford in England, said in a university news release.

"Using this information, we can hopefully soon make a solid argument to support the scaling-up of early diagnosis and antiviral treatment in drug users," Magiorkinis said. "Helping these people and stopping the spread of hepatitis C is our ultimate target."

The study was published Jan. 31 in the journal PLoS Computational Biology.

Up to 180 million people worldwide are infected with hepatitis C, but many don't know it and go undiagnosed for more than 10 years.

"Working out how many people are likely to be infected by each 'super-spreader' of hepatitis C, as well as how soon they will be infected, has been a puzzle for over 20 years," Magiorkinis said.

"Our research has resolved this issue and paves the way for a modeling study to show what kind of public health interventions could really make a difference," he added
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
2. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
3. Bundlevid.Me: New Apple iPhone App Bundlevid Brings Easy Video Journaling to iPhone Users
4. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
5. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
6. New ChairMaster™ Fitness Chair Lets Users Sit and Get Fit
7. Voice Activated PDA for Blind and Low Vision Users from LS&S Now Offered by Rehabmart
8. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
9. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
10. myMEDholiday Comes up with a New Highly Credible Informative Website for Users Looking for Affordable Healthcare Centers Abroad
11. Kids With Autism Common Users of ERs, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, ... surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned ... many patients from around the world. , “Like treatment of any other disease or ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... State-designated entity on behalf of the New Jersey Department of Health, has received ... Information Technology, an agency of the U.S. Department of Health and Human Services ...
(Date:7/30/2015)... ... 2015 , ... New research finds some distinct differences in the way mesothelioma ... the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, the ... of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) occurred ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... Bird ... offers a new bird hazing system to repel pest birds from the ... 60 diseases—including histoplasmosis, encephalitis, salmonella, meningitis, and toxoplasmosis, even the West Nile virus. When ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Author Dr. ... charge of their health in his new self-help book, “ Consciously Healing our Webs ... book promotes a simple message: “If we take responsibility for ourselves, we can create ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3
... to Fund Medical Assistance /MinnesotaCare Outreach and Enrollment Effort ... 13 Portico Healthnet, a non-profit agency working to ... care services, has been awarded more than $988,000 by ... to launch the Minnesota Coalition for Kids Health Coverage, ...
... WALTHAM, Mass., Oct. 13 Interleukin Genetics, Inc. (NYSE Amex: ... the fields of obesity and osteoporosis at medical meetings later this ... (ADA) Food and Nutrition Conference & Expo in Denver, Colo. ... IDF 20th World Diabetes Congress - Montreal, Canada . , ...
... Revenues for the US and European medical technology industry ... growth flattened out in the first half of 2009 ... seeks to maintain long-term momentum, including a stubborn funding ... and reimbursement environment. These and other findings are highlighted ...
... policies recommending that non-invasive ventilation be avoided during an ... link only http://www.cmaj.ca/embargo/cmaj081987.pdf ) in CMAJ ... argues that it should be used expeditiously in this ... to ventilate the lungs of patients in respiratory failure, ...
... ... medication information and rebate coupons through its physician network. Vivacare has recently enhanced the ... ... 13, 2009 -- Vivacare has made it easier for doctors to ...
... ... chairs into ergonomic computer workstations , ... Salisbury, NC (PRWEB) October 13, 2009 -- ErgoBiz, LLC, a manufacturer ... a revolutionary computer accessory that quickly converts most standard office chairs into an ergonomic ...
Cached Medicine News:Health News:Portico Healthnet Awarded $988K to Launch MN Coalition for Kids Health Coverage 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 3Health News:Global Medtech Industry Holds Steady Amidst Recession 2Health News:Global Medtech Industry Holds Steady Amidst Recession 3Health News:Global Medtech Industry Holds Steady Amidst Recession 4Health News:Should noninvasive ventilation be considered a high-risk procedure during an epidemic? 2Health News:Vivacare Delivers Medication Information to Patients through Doctor Websites 2Health News:Vivacare Delivers Medication Information to Patients through Doctor Websites 3Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 3
(Date:7/30/2015)... Net Sales of $1.17 billion represent a decrease of 1.3% ... 5.7% constant currency , Reported net loss per share ... share were $1.59, an increase of 0.6% over the prior ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... Company reported second quarter net sales of $1.17 billion, a ...
(Date:7/29/2015)... , July 30, 2015 Roche (SIX: RO, ... the cobas® EGFR Mutation Test v2 for Premarket ... Administration (FDA), as a companion diagnostic test for ... lung cancer patients with an acquired resistant mutation.  ... cancer who have adenocarcinoma with tumor containing an ...
(Date:7/29/2015)...  Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced the ... Company with flexibility and control to support its continued ... equity purchase agreement for up to $45 million with ... Chicago -based institutional investor, which provides the Company ...
Breaking Medicine Technology:Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 2Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 3Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
... from a Children's Oncology Group (COG) Study ... Meeting -, CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ ... on developing monoclonal,antibodies to treat cancer and ... epratuzumab plus standard,chemotherapy is feasible and well ...
... Plenary Session Reports EORTC 40983 (EPOC),Intergroup Study ... Results of the,randomized phase III EORTC 40983 ... first time that peri-operative (pre and post,surgery) ... standard chemotherapy regimen for colon cancer,5-fluorouracil/leucovorin (5-FU/LV)) ...
Cached Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: